...
首页> 外文期刊>Diabetes care >Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
【24h】

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

机译:Candesartan在“降低死亡率和发病率(CHARM)的心力衰竭评估”中对慢性心力衰竭患者糖尿病的发展进行了预测。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The purpose of this study was to identify predictors of incident diabetes during follow-up of nondiabetic patients with chronic heart failure (CHF) in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. RESEARCH DESIGN AND METHODS: A total of 1,620 nondiabetic patients had full baseline datasets. We compared baseline demographic, medication, and laboratory data for patients who did or did not develop diabetes and conducted logistic regression and receiver operator characteristic curve analyses. RESULTS: Over a median period of 2.8 years, 126 of the 1,620 patients (7.8%) developed diabetes. In multiple logistic regression analysis, the following baseline characteristics were independently associated with incident diabetes in decreasing order of significance by stepwise selection: higher A1C (odds ratio [OR] 1.78 per 1 SD increase; P < 0.0001), higher BMI (OR 1.64 per 1 SD increase; P < 0.0001), lipid-lowering therapy (OR 2.05; P = 0.0005), lower serum creatinine concentration (OR 0.68 per 1 SD increase; P = 0.0018), diuretic therapy (OR 4.81; P = 0.003), digoxin therapy (OR 1.65; P = 0.022), higher serum alanine aminotransferase concentration (OR 1.15 per 1 SD increase; P = 0.027), and lower age (OR 0.81 per 1 SD increase; P = 0.048). Using receiver operating characteristic curve analysis, A1C and BMI yielded areas under the curve of 0.723 and 0.712, respectively, increasing to 0.788 when combined. Addition of other variables independently associated with diabetes risk minimally improved prediction of diabetes. CONCLUSIONS: In nondiabetic patients with CHF in CHARM, A1C and BMI were the strongest predictors of the development of diabetes. Other minor predictors in part reflected CHF severity or drug-associated diabetes risk. Identifying patients with CHF at risk of diabetes through simple criteria appears possible and could enable targeted preventative measures.
机译:目的:本研究的目的是在坎地沙坦《心衰减少死亡率和发病率评估》(CHARM)计划中,对非糖尿病慢性心力衰竭(CHF)患者进行随访期间糖尿病事件的预测指标。研究设计和方法:共有1,620名非糖尿病患者具有完整的基线数据集。我们比较了患有或未患糖尿病的患者的基线人口统计学,药物治疗和实验室数据,并进行了逻辑回归和接受者操作者特征曲线分析。结果:在2.8年的中位期间,1,620名患者中有126名(7.8%)患了糖尿病。在多元逻辑回归分析中,以下基线特征与糖尿病的发生率相关性通过逐步选择以显着性递减的方式独立相关:较高的A1C(比值比[OR] 1.78 /每1 SD增加; P <0.0001),较高的BMI(比值OR 1.64 /每增加1 SD; P <0.0001),降脂治疗(OR 2.05; P = 0.0005),降低血清肌酐浓度(每1 SD增加OR 0.68; P = 0.0018),利尿治疗(OR 4.81; P = 0.003),地高辛疗法(OR 1.65; P = 0.022),较高的血清丙氨酸氨基转移酶浓度(OR每增加1 SD 1.15; P = 0.027)和年龄降低(OR每增加1 SD SD 0.81; P = 0.048)。使用接收器工作特性曲线分析,A1C和BMI分别在曲线0.723和0.712下产生面积,组合时增加到0.788。独立地与糖尿病相关联的其他变量的风险最小程度地改善了对糖尿病的预测。结论:在CHARM为CHF的非糖尿病患者中,A1C和BMI是糖尿病发展的最强预测因子。其他次要预测指标部分反映了CHF严重程度或与药物相关的糖尿病风险。通过简单的标准识别患有糖尿病风险的CHF患者似乎是可能的,并且可以采取针对性的预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号